Atara Biotherapeutics ATRA
NASDAQ ATRA
$9.43 +0.08 (+0.86%)
At close: Oct 22, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Non Operating Interest Expenses (2022 - 2026)

Updated

Atara Biotherapeutics' Non Operating Interest Expenses was $191,000 in Q2 2026, down 80.3% from $972,000 a year earlier and down 77.0% from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Atara Biotherapeutics' Non Operating Interest Expenses was $2.82 million through Jun 30, 2026, down 32.6% year-over-year; for FY2025, it came in at $3.79 million, down 17.8% from FY2024.

  • Non Operating Interest Expenses shows a three-year compound annual growth rate of 116.6% (FY2022 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $4.62 million in FY2024 (-12.7%), $5.29 million in FY2023 and $373,000 in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Non Operating Interest Expenses since Q4 2022.
  • Compared with a year earlier, Non Operating Interest Expenses has declined for ten straight quarters, with an average decline of 24.7% over the last eight quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2023 (growth of 968.2%); the worst was Q2 2026 (a decline of 80.3%).
  • Per Business Quant data, ATRA's Non Operating Interest Expenses in the three quarters before Q2 2026 was $830,000 (Q1 2026), $894,000 (Q4 2025) and $909,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Atara Biotherapeutics 141.16 Mn 131.26 Mn 439,000.00 191,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 191,000.00
Mar 31, 2026 830,000.00
Dec 31, 2025 894,000.00
Sep 30, 2025 909,000.00
Jun 30, 2025 972,000.00
Mar 31, 2025 1.02 Mn
Dec 31, 2024 1.02 Mn
Sep 30, 2024 1.18 Mn
Jun 30, 2024 1.26 Mn
Mar 31, 2024 1.15 Mn
Dec 31, 2023 1.18 Mn
Sep 30, 2023 1.40 Mn
Jun 30, 2023 1.38 Mn
Mar 31, 2023 1.34 Mn
Dec 31, 2022 117,000.00
Sep 30, 2022 123,000.00
Jun 30, 2022 129,000.00
Mar 31, 2022 4,000.00
API Access

Atara Biotherapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ATRA&period=max&api_key=YOUR_API_KEY